References
Allan JM, Travis LB . Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer 2005; 5: 943–955.
Worrillow LJ, Travis LB, Smith AG, Rollinson S, Smith AJ, Wild CP et al. An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents. Clin Cancer Res 2003; 9: 3012–3020.
Zhu YM, Das-Gupta EP, Russell NH . Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia. Blood 1999; 94: 733–740.
Ross DD, Chen SR, Cuddy DP . Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution. Cancer Res 1990; 50: 2658–2666.
Arnaudeau C, Lundin C, Helleday T . DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells. J Mol Biol 2001; 307: 1235–1245.
Meyers M, Wagner MW, Mazurek A, Schmutte C, Fishel R, Boothman DA . DNA mismatch repair-dependent response to fluoropyrimidine-generated damage. J Biol Chem 2005; 280: 5516–5526.
Takahashi T, Min Z, Uchida I, Arita M, Watanabe Y, Koi M et al. Hypersensitivity in DNA mismatch repair-deficient colon carcinoma cells to DNA polymerase reaction inhibitors. Cancer Lett 2005; 220: 85–93.
Morrison VA, Rai KR, Peterson BL, Kolitz JE, Elias L, Appelbaum FR et al. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. J Clin Oncol 2002; 20: 3878–3884.
Acknowledgements
This work was supported by Leukemia and Lymphoma Research, UK (Grant no. 06002 to JMA).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Fordham, S., Matheson, E., Scott, K. et al. DNA mismatch repair status affects cellular response to Ara-C and other anti-leukemic nucleoside analogs. Leukemia 25, 1046–1049 (2011). https://doi.org/10.1038/leu.2011.38
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2011.38
- Springer Nature Limited
This article is cited by
-
Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia
Scientific Reports (2020)
-
Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia
Leukemia (2015)
-
Cytosine-based nucleoside analogs are selectively lethal to DNA mismatch repair-deficient tumour cells by enhancing levels of intracellular oxidative stress
British Journal of Cancer (2013)
-
DNA repair dysregulation from cancer driver to therapeutic target
Nature Reviews Cancer (2012)